Juvenile dermatomyositis in Child
Childhood type dermatomyositis, also known as juvenile dermatomyositis (JDM), is an idiopathic multisystem inflammatory disorder where muscle inflammation is accompanied by a skin rash. It is typically first detected in children aged between 2 and 15 years.
Cutaneous lesions may precede muscle disease by anywhere from weeks to more than 4 years and may be extremely pruritic. Exposure to sunlight may exacerbate the cutaneous lesions. Other characteristic features may include flat erythema of the upper back and posterior neck and shoulders (shawl sign) as well as a similarly presenting macular erythema of the anterior neck and upper chest (V sign) that can worsen with ultraviolet (UV) exposure. Patients may also have poikiloderma over the lateral hip (holster sign). Myositis (inflammation of muscle) usually develops insidiously, but sometimes abruptly, or may not occur at all (amyopathic or hypomyopathic dermatomyositis).
Muscle findings include symmetric proximal muscle weakness, usually of the shoulder and pelvic girdles.
In acute phases, pain and tenderness may occur and palpation may have a doughy feel. In addition, the patient's gait may be abnormal. Patients may complain of difficulty climbing stairs and brushing their hair. Upper palatal muscle and esophageal dysfunction may be noted, resulting in dysphonia, dysphagia, anorexia, and weight loss. Neck flexors are usually weak, and the patient may be unable to raise his or her head at all. Fever and fatigue are other common symptoms, and patients may also report arthralgia.
While children experience calcinosis cutis, muscle necrosis, and gingival and periungual telangiectasias more frequently than adults, JDM is a milder disease overall than adult dermatomyositis. There is a lower frequency of interstitial lung disease and lower overall mortality. Moreover, the association of malignancy with dermatomyositis is extremely uncommon in JDM.
Signs of severity in childhood include systemic vasculopathy, resulting in ulcerative disease of the skin and other organs (especially in the lungs or gastrointestinal tract), high severity of muscle disease, and endomysial fibrosis on muscle biopsy. The presence of these signs may indicate disease that is refractory to first-line treatment.
Dermatomyositis may be induced by medications, usually seen in adults, including hydroxyurea, penicillamine, interferon beta, statins, and ipilimumab. Acute onset / flares of dermatomyositis have been reported in association with ingestion of IsaLean, an herbal supplement.
Acquired lipodystrophy and acanthosis nigricans occurring in the setting of insulin resistance has infrequently been reported with JDM.
M33.00 – Juvenile dermatomyositis, organ involvement unspecified
1212005 – Juvenile dermatomyositis
- For patients with myositis, one must rule out other systemic causes of myopathy (eg, thyroid disorders, electrolyte disturbances, vitamin D deficiency, mitochondrial / metabolic myopathies, or infection) and distinguish JDM from other connective tissue diseases such as polymyositis, mixed connective tissue disease, and systemic lupus erythematosus (SLE). In JDM, fingers may appear more sausage-like than with SLE.
- Juvenile polymyositis is a rare form of idiopathic inflammatory myopathy seen in the pediatric population.
- Acute lesions of erythropoietic protoporphyria may have similar locations, especially on the dorsum of the hands, but usually there is no muscle weakness.
- Scalp involvement may be present in the majority of patients but is frequently misdiagnosed as psoriasis or seborrheic dermatitis.
- Atopic dermatitis
- Lichen planus
- Polymorphous light eruption
- Phototoxic / photoallergic drug eruptions
- Acute graft-versus-host disease
- HIV infection
- Acral erythema